**3. Future prospects of CSF studies for viral encephalitis**

Current diagnostic methods which have been described above have been providing valua‐ ble proves for diagnostic process of the viral encephalitis but new approaches are needed with increased knowledge of pathogenesis of viral encephalitis. These are must be combined according to clinical picture and possible etiological agents. These promising methods are;

of encephalitis: clinical practice guidelines by the infectious diseases society of Amer‐

Cerebrospinal Fluid Abnormalities in Viral Encephalitis

http://dx.doi.org/10.5772/54590

31

[2] Rantalaiho T, Farkkila M, Vaheri A, Koskinemiemi M. Acute encephalitis from 1967

[3] Steiner I, Schmutzhard E, Sellner J, Chaudhuri A, Kennedy PG. EFNS-ENS guide‐ lines for the use of PCR technology for the diagnosis of infections of the nervous sys‐

[4] Chaudhuri A, Kennedy PGE. Diagnosis and treatment of viral encephalitis. Journal

[5] Ziai WC, Lewin III JJ, Update in the diagnosis and management of central nervous

[6] Romero JR, Newland JG, Diagnosis of viral encephalitides: Nonzoonotic-associated

[7] Jakob NJ, Lenhard TL, Schnitzler P, Rohde S, Ringleb PA, Steiner T, Wildemann B, Herpes simplex virus encephalitis despite normal cell count in the cerebrospinal flu‐

[8] Ziyaeyan M, Alborzi A, Haghighi AB, Moeini M, Pourabbas B, Diagnosis and quanti‐ tative detection of HSV DNA in samples from patients with suspected herpes sim‐

[9] Ambrose HE, Granerod J, Clewley JP, Davies NWS, Keir G, Cunningham R, Zucker‐ man M, Mutton KJ, Ward KN, Ijaz S, Crowcroft NS, Brown DWG, on behalf of the UK Aetiology of encephalitis study group, Diagnostic strategy to establishetiologies of encephalitis in a prospective cohort of patients in england, Journal of clinical mi‐

[10] Kamei S, Taira N, Ishikara M, Sekizawa T, Morita A, Miki K, Shiota H, Kanno A, Su‐ zuki Y, Mizutani T, Itoyama Y, Morishima T, Hirayanagi K, Prognostic value of cere‐ brospinal fluid cytokine changes in herpes simplex virus encephalitis, Cytokine 46

[11] Grahn A, Studahl M, Nilsson S, Thomsson E, Backström M, Bergström T, Varicellazoster virus (VZV) glycoprotein E is a serological antigen for detection of intrathecal antibodies to VZV in central nervous system infections, without cross-reaction to

herpes simplex virus 1, Clinical and Vaccine immunology, 18 (2011) 1336-1342

[14] Misra UK, Kalita J, Overview: Japanese encephalitis, Progress in Neurobiology 91

[12] LaSala PR, Holbrook M, Tick-Borne Flaviviruses, Clin Lab Med 30 (2010) 221-235

[13] Rossi SL, Ross TM, Evans JD, West nile virus, Clin Lab Med 30 (2010) 47-65

to 1991. Journal of the Neurological Sciences 2001; 184: 169 – 177.

viruses, The pediatric infectious disease journal, 25 (2006) 739-740

ica, Clin Infect Dis 47 (2008) 303-327

tem. Eur J Neurol. 2012 Aug 6. doi: 10.1111/j.

of postgraduate Medicine 2002; 78: 575 – 583.

system infections, Neurol Clin 26 (2008) 427-468

plex encephalitis, Braz J Infect Dis 15(3) (2011), 211-214

id, Crit care med 40 (2012)1304-1308)

crobiology 49 (2011) 3576-3583.

(2009) 187-193

(2010) 108-120


Related to future prospects of diagnostic methods which will evaluate biomarkers in CSF must be improved as diagnostic and also prognostic methods.
